Status
Conditions
Treatments
About
Until now, cancer is still associated with high morbidity and mortality, and is therefore a big issue for the public health. Colorectal cancer is the second leading cause of cancer death in developed countries. In advanced colorectal cancer, 60% of these patients develop cachexia. The presence of cachexia plays an important role in the high mortality rate of cancer. Cachexia is characterized by involuntary weight loss with loss of skeletal muscle with or without loss of fat mass.
The aim of this study is to determine the feasibility of taking muscle biopsies of cachectic colorectal cancer patients. Skeletal muscle characteristics will be compared between biopsies of the m. erector spinae and the m. vastus lateralis from cachectic colorectal cancer patients, non-cachectic colorectal cancer patients and healthy controls.
10 cachectic, 25 non-cachectic, and 25 healthy controls will be recruited for this study. It is an observational study, so measurements will be taken at one time point. Interventions/measurements:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Cachectic colorectal cancer patients.
Inclusion criteria:
Exclusion Criteria:
Non-Cachectic cancer patients.
Inclusion criteria:
Exclusion criteria:
Healthy controls.
Inclusion criteria:
- minimum age of 18 years old
Exclusion criteria:
60 participants in 3 patient groups
Loading...
Central trial contact
Britt van de Haterd, PhD student; Kenneth Verboven, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal